Overweight and obesity are major public health problems in the 21st century, and considerable efforts into understanding the causative genetic and environmental factors are...
Vanda Pharmaceuticals Inc. (Vanda) announced it has entered into a License Agreement (the License Agreement) with MSN Pharmaceuticals Inc., MSN Laboratories Private Limited (together...
AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...
Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...
Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address critical problems in public health—from the opioid crisis to the Covid-19 pandemic, as well...
